Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)

Historic Acquisitions for Collegium Pharmaceutical (COLL) over the last 2 years, with Q1 2022 value amounting to $572.1 million.

  • Collegium Pharmaceutical's Acquisitions changed N/A to $572.1 million in Q1 2022 from the same period last year, while for Dec 2022 it was $572.1 million, marking a year-over-year change of. This contributed to the annual value of $267.5 million for FY2024, which is N/A changed from last year.
  • As of Q1 2022, Collegium Pharmaceutical's Acquisitions stood at $572.1 million.
  • In the past 5 years, Collegium Pharmaceutical's Acquisitions ranged from a high of $572.1 million in Q1 2022 and a low of $116000.0 during Q2 2018